Acute Porphyria Drug Database

Monograph

B01AC13 - Abciximab
Not porphyrinogenic
NP

Rationale
Polypeptide. No CYP-interactions.
Chemical description
Fab-fragment of the chimeric monoclonal antibody 7E3, binds to and blocks a platelet surface receptor. Used together with ASA and heparin as i.v. infusion 0.25 mg/kg BW, in percutaneous coronary intervention.

Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
ReoPro ยท ReoPro 10mg/5ml solution for injection vials
 
© NAPOS 2024
An unhandled error has occurred. Reload ๐Ÿ—™